Takeda Pharmaceutical (TAK) Shares Outstanding (Diluted) (2017 - 2026)
Takeda Pharmaceutical (TAK) recorded Shares Outstanding (Diluted) of 143.19 million in the quarter ended Jun 30, 2026, down 1.9% from 145.94 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Shares Outstanding (Diluted) (2017 - 2026) Analysis & Trends
Starting with the quarter ended Mar 31, 2018, Takeda Pharmaceutical's Shares Outstanding (Diluted) history includes 29 quarters.
- Annual Shares Outstanding (Diluted) has a five-year compound annual growth rate of 0.0% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Shares Outstanding (Diluted) came in at 145.94 million in the year ended Mar 31, 2025 (+1.6%), 143.67 million in the year ended Mar 31, 2024 (+0.7%), 142.72 million in the year ended Mar 31, 2023 (-0.5%) and 143.38 million in the year ended Mar 31, 2022 (+0.2%).
- Quarterly Shares Outstanding (Diluted) has ranged from 142.72 million in the quarter ended Mar 31, 2023 to 145.94 million in the quarter ended Dec 31, 2025 over the past five years.
- On a year-over-year basis, Shares Outstanding (Diluted) rose in six of the last eight quarters, with growth averaging 0.5%.
- Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 1.6% in the quarter ended Dec 31, 2025, against a decline of 1.9% in the quarter ended Mar 31, 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 143.19 million (quarter ended Mar 31, 2026), 145.94 million (quarter ended Dec 31, 2025) and 145.94 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn | 143.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143.19 Mn |
| Mar 31, 2026 | 143.19 Mn |
| Dec 31, 2025 | 145.94 Mn |
| Sep 30, 2025 | 145.94 Mn |
| Jun 30, 2025 | 145.94 Mn |
| Mar 31, 2025 | 145.94 Mn |
| Dec 31, 2024 | 143.67 Mn |
| Sep 30, 2024 | 143.67 Mn |
| Jun 30, 2024 | 143.67 Mn |
| Mar 31, 2024 | 143.67 Mn |
| Dec 31, 2023 | 142.72 Mn |
| Sep 30, 2023 | 142.72 Mn |
| Jun 30, 2023 | 142.72 Mn |
| Mar 31, 2023 | 142.72 Mn |
| Dec 31, 2022 | 143.38 Mn |
| Sep 30, 2022 | 143.38 Mn |
| Jun 30, 2022 | 143.38 Mn |
| Mar 31, 2022 | 143.38 Mn |
| Jun 30, 2021 | 143.05 Mn |
| Mar 31, 2021 | 143.05 Mn |
API Access
Takeda Pharmaceutical Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();